We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$171B
Turnover
10.62%
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter
Est. Return
-0.2%
1 Year Est. Return
+24.68%
3 Year Est. Return
+62.17%
5 Year Est. Return
+55.89%
10 Year Est. Return
+171.9%
AUM
$147B
AUM Growth
+$7.72B
(+5.5%)
Cap. Flow
+$9.48B
Cap. Flow
% of AUM
6.43%
Top 10 Holdings %
Top 10 Hldgs %
41.95%
Holding
4,221
New
328
Increased
2,776
Reduced
891
Closed
131
Avg Time Held Equity + Options
4.2
years
Top 10 Avg Time Held Equity + Options
1.5
years
Top 20 Avg Time Held Equity + Options
4
years
Avg Time Held Equity only
4.2
years
Top 10 Avg Time Held Equity only
1.5
years
Top 20 Avg Time Held Equity only
4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$888M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$700M |
| 3 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$408M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$338M |
| 5 |
Vanguard Russell 1000 Value ETF
VONV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$248M |
| 2 |
Schwab US Large- Cap ETF
SCHX
|
+$41.4M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$39.9M |
| 4 |
Schwab US Large-Cap Value ETF
SCHV
|
+$34.6M |
| 5 |
Schwab US Mid-Cap ETF
SCHM
|
+$32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 75.77% |
| 2 | Technology | 8.02% |
| 3 | Financials | 3.7% |
| 4 | Industrials | 2.22% |
| 5 | Healthcare | 2.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2851
Oruka Therapeutics
ORKA
$4.93B
| $625K | ﹤0.01% |
12,736
+5,040
| +65% | +$175K |
2025 Q4
1 quarter
|
|
2852
Zumiez
ZUMZ
$221M
| $624K | ﹤0.01% |
28,159
+927
| +3% | +$22.6K |
2025 Q4
1 quarter
|
|
2853
Camtek
CAMT
$5.94B
| $623K | ﹤0.01% |
4,110
+36
| +0.9% | +$5.46K |
2024 Q3
6 quarters
|
|
2854
Ironwood Pharmaceuticals
IRWD
$623M
| $623K | ﹤0.01% |
177,520
+15,445
| +10% | +$63.3K |
2021 Q2
19 quarters
|
|
2855
Nuveen Municipal Value Fund
NUV
$1.73B
| $621K | ﹤0.01% |
69,041
-84
| -0.1% | -$767 |
2013 Q2
51 quarters
|
|
2856
Eaton Vance Tax-Managed Diversified Equity Income Fund
ETY
$2.23B
| $620K | ﹤0.01% |
44,987
+594
| +1% | +$8.77K |
2022 Q1
16 quarters
|
|
2857
Invesco BulletShares 2030 Corporate Bond ETF
BSCU
$2.78B
| $620K | ﹤0.01% |
37,085
+2,646
| +8% | +$44.7K |
2025 Q1
4 quarters
|
|
2858
Federal Agricultural Mortgage
AGM
$2.23B
| $620K | ﹤0.01% |
4,178
-5,430
| -57% | -$888K |
2021 Q3
18 quarters
|
|
2859
Oscar Health
OSCR
$10.4B
| $620K | ﹤0.01% |
54,016
-15,279
| -22% | -$215K |
2024 Q1
8 quarters
|
|
2860
Green Plains
GPRE
$1.02B
| $619K | ﹤0.01% |
37,635
+9,812
| +35% | +$133K |
2025 Q1
4 quarters
|
|
2861
Heartland Express
HTLD
$854M
| $619K | ﹤0.01% |
59,514
+5,921
| +11% | +$62.5K |
2024 Q2
7 quarters
|
|
2862
Fidelity Enhanced Mid Cap Core ETF
FMDE
$8.3B
| $618K | ﹤0.01% |
17,199
+1,058
| +7% | +$39.2K |
2023 Q4
9 quarters
|
|
2863
iShares US Small Cap Equity Factor ETF
SMLF
$4.09B
| $618K | ﹤0.01% |
8,186
+1
| +0% | +$78 |
2025 Q2
3 quarters
|
|
2864
DRDGold
DRD
$2.14B
| $616K | ﹤0.01% |
20,990
+69
| +0.3% | +$2.29K |
2022 Q3
14 quarters
|
|
2865
Otter Tail
OTTR
$3.76B
| $616K | ﹤0.01% |
7,021
+973
| +16% | +$84.2K |
2023 Q2
11 quarters
|
|
2866
Arvinas
ARVN
$466M
| $616K | ﹤0.01% |
58,120
+1,193
| +2% | +$14.8K |
2024 Q4
5 quarters
|
|
2867
MSC Income Fund Inc
MSIF
$533M
| $615K | ﹤0.01% |
50,526
+27,179
| +116% | +$352K |
2025 Q3
2 quarters
|
|
2868
iMGP DBi Managed Futures Strategy ETF
DBMF
$4.4B
| $614K | ﹤0.01% |
20,380
-2,840
| -12% | -$85.1K |
2023 Q1
12 quarters
|
|
2869
Pacira BioSciences
PCRX
$1.45B
| $614K | ﹤0.01% |
27,153
-7,310
| -21% | -$162K |
2024 Q2
7 quarters
|
|
2870
Diamondrock Hospitality Co
DRH
$2.7B
| $613K | ﹤0.01% |
65,446
+22,911
| +54% | +$218K |
2025 Q2
3 quarters
|
|
2871
Red Cat Holdings
RCAT
$733M
| $613K | ﹤0.01% |
46,817
+32,596
| +229% | +$445K |
2025 Q4
1 quarter
|
|
2872
ADMA Biologics
ADMA
$2.41B
| $612K | ﹤0.01% |
67,933
+5,394
| +9% | +$85.1K |
2024 Q1
8 quarters
|
|
2873
Kiniksa Pharmaceuticals
KNSA
$6.24B
| $611K | ﹤0.01% |
12,687
+1,205
| +10% | +$53.4K |
2025 Q2
3 quarters
|
|
2874
H2O America
HTO
$2.43B
| $610K | ﹤0.01% |
10,397
+663
| +7% | +$36.1K |
2022 Q1
16 quarters
|
|
2875
ZTO Express
ZTO
$14.9B
| $608K | ﹤0.01% |
24,149
+3,302
| +16% | +$77.4K |
2022 Q3
14 quarters
|
|
Similar funds
Creative Planning's Q1 2026 Portfolio in Review
As of Q1 2026, Creative Planning held 4,221 positions worth $147B, up 5.5% from $140B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Creative Planning deployed $9.48B of net new capital in Q1 2026, opening 328 new positions and adding to 2,776 existing holdings. Its largest new stake was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 76% of assets, down from 76% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $248M trimmed.
- Creative Planning's largest Q1 2026 buy was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.
- Creative Planning added most to Vanguard Short-Term Bond ETF in Q1 2026, an estimated $888M increase.
- Creative Planning's biggest Q1 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $248M.
- Creative Planning fully exited CyberArk in Q1 2026, selling an estimated $9.29M.
- Creative Planning's ten largest holdings make up 42% of its $147B portfolio in Q1 2026.
- Creative Planning opened 328 new positions and closed 131 in Q1 2026.
- Creative Planning's portfolio value rose 5.5% quarter-over-quarter to $147B.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.